Treace Medical Concepts, Inc. (TMCI) Tops Q3 EPS by 2c

Treace Medical Concepts, Inc. (NASDAQ: TMCI) reported Q3 EPS of ($0.25), $0.02 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $45.08 million versus the consensus estimate of $43.48 million.

For earnings history and earnings-related data on Treace Medical Concepts, Inc. (TMCI) click here.

You May Also Be Interested In

• Crude Inventory Fell 1.7 Million Barrels Last Week - EIA
• Goldman Sachs (GS) PT Raised to $1,190 at BMO Capital
• Wolfe Research comments on PayPal (PYPL) rumors